Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Timing rebalancing for tax efficiency involves evaluating thresholds and market conditions. This intro offers actionable timing tips for index funds.
17,111 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
A long-running insurer broker, founded in 1941, has quietly raised its dividends for decades and now offers a compell...
A Tuesday pullback in COP shares left investors weighing oil prices, broker notes, and the long-term outlook for ener...
A brutal 2022 bond selloff upended the notion that fixed income always delivers safety. With inflation stubborn and r...
A shrinking Western business presence in Russia is exposing both risk and opportunity for investors as sanctions tigh...
Reddit still furious about AT&T's $47 billion write-down lingers as a new buyer group targets the legacy assets for r...
Rocket Lab and AST SpaceMobile sit on opposite ends of the space-investing spectrum. This guide breaks down what each...
The Middle East crisis is sending shockwaves through the stock market, but airlines are taking the biggest hit. This ...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Bitcoin climbs to a six week high while Ethereum tops $2,200 as the crypto rally broadens. CoinGlass data shows about...
When money patterns become a repeat cycle, the only sane move is to cut the triggers. This article explains how the n...
As GenAI reshapes software, security becomes non-negotiable. Here are three cybersecurity stocks generative AI advoca...